About
Founded in May 2021, SynapCon(c) GmbH develops advanced technologies and business models with a clear focus on accelerating the clinical development of drugs and medical devices.
We make products available to patients more quickly and reducing the burden on healthcare systems in the long term.
Thanks to the recent notice to sponsors from the EMA our product has never seen a better time to show off its capabilities.
Our Vision
We want to bring fast, efficient, affordable and reliable healthcare solutions to every human being on this planet. Clinical trials are one critical waypoint (or bottleneck) to pass for every IVD, drug or medical device manufacturer. This is why we decided to focus on improving these trials as a massive multiplication hub.
Based on our professional experience and the knowledge generated, a new development funded by the European Union was created from 2017 onwards. It implements the latest findings and requierements in IT and regulations as standards. Since 2021, the new systems are available and successfully in use to the full satisfaction of customers.
Start-up medical device producer wound care
“The technical and regulatory expertise of
SynapCon is outstanding.“
Leading European CRO in the field of regulatory affairs, clinical studies P II-IV, NIS and PMS
EasyTMF® Vendor Qualified (GAMP5_second edition)
“The ease of use, functionality and transparency of EasyTMF(r) keeps us competitive”.
Global medical device producer ophthalmology
EasyTMF® Vendor Qualified (GAMP5_second edition)
“The price-performance ratio in combination with the regulatory expertise is convincing.“
John Giantsidis, President of CyberActa
"Randomized Controlled Trials (RCTs) have long been the gold standard for drug evaluation. However, Real-World Evidence (RWE) is increasingly being used by regulatory agencies, healthcare professionals and pharmaceutical companies. SynapCon's use of Veridat 's technology provides a secure, transparent and tamper-proof method for tracking and verifying clinical data, RWD and RWE ensuring its authenticity throughout its lifecycle".
Awards & Recognition
2021
2022
2023
2024
2025 2026
Awards & Recognition
We are proud to be recognised by leading institutions for our innovation, quality, and impact in digital clinical research and organizational excellence.
​
Corporate & Employer
​​​
SynapCon has been recognised multiple times for its innovation and forward-thinking corporate culture — as
“Best Employer of the Future 2023” (DVAG / German Innovation Institute),
“Business Innovator” (DUP UNTERNEHMER / WirtschaftsWoche Group),
and 2nd Place Winner of the “Best of Technology Award 2024” by WirtschaftsWoche.
These distinctions affirm our mission to unite sustainable digitalisation, scientific excellence, and responsible leadership — shaping an innovative, connected, and more human future in clinical research.
​​
Industry & Product (Clinical Trials & Life Sciences)
​
-
Best Clinical Trial Management System — Clinical Trial Management System & GHP Clinical Research Innovation Excellence Award (2021, 2023)
-
Best Clinical Trial Management System (Global) — M&A Today Global Awards (2022, 2023, 2025, 2026)
-
Best Clinical Research Software Distributor 2022 — GHP Private Healthcare Awards (2022)
-
Best Biotech Development Software, Germany — Corporate LiveWire (2022, 2023)
-
Best Clinical Development Solutions Company 2023 — International Life Sciences Global Awards (2022/23)
-
Best Clinical Trial & Medical Research Software Solutions Company 2024 (Europe) — Corporate Vision – Corporate Excellence Awards
-
Best Pharma & Biotech Clinical Trials Digitisation Company 2024 — GHP Biotech Innovation Excellence Award 2024
-
Best Clinical Trial Management System (UK) 2025 — M&A Today Global Awards 2025